As
reported in the August 2007 Journal of Viral Hepatitis, 1641 hepatitis
C patients recruited from 8 European centers in 1996-1997 (the HENCORE cohort)
were re-analyzed 5-7 years after enrollment. The occurrence of decompensated cirrhosis,
HCC, and liver transplantation was analyzed in relation to different host and
viral factors.
Results
93%
of the patients who had cleared the virus spontaneously or after antiviral therapy
remained HCV RNA negative during follow up and may be considered "cured."
Among patients who were sustained virological responders
at inclusion, just 2.3% developed liver complications during follow up, compared
with 31% of treatment non-responders.
Older age at the time of infection and presence of the
human leukocyte antigen (HLA) DRB1*1201-3 allele were possibly associated with
a higher rate of progression to decompensated cirrhosis or HCC.
Decompensated cirrhosis might be further associated with
male sex, non-response to previous therapy, and lack of the HLA DRB1*1301 allele,
while HCC seems to be associated with the presence of the HLA DQ02 allele.
Conclusion
"Long-term
follow up of HCV patients indicates that virological response persists over time
and is associated with a very low incidence of liver complications," the
study authors wrote.
They added that, "Advanced age at inclusion,
advanced age at infection, viral genotype 1, non-response to previous therapy
and possibly some specific HLA alleles are factors independently associated with
a faster rate of progression towards liver complications."
08/24/07
Reference P
Pradat, HL Tillmann, S Sauleda, and others. Long-term follow-up of the hepatitis
C HENCORE cohort: response to therapy and occurrence of liver-related complications.
Journal of Viral Hepatitis 14(8): 556-563. August 2007.